The Centre's decision to ban pharmaceutical exports to Pakistan after the Pahalgam terror attack will have negligible impact on Himachal Pradesh's pharma industry as little business was transacted with the country. Even as the Baddi Barotiwala Nalagarh (BBN) Industrial Area is acclaimed as the pharmaceutical hub of Asia, Pakistan has never been a choice for pharma exports, say experts.